capecitabine has been researched along with vorinostat in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Deng, X; Feng, H; Feng, Y; He, Y; Jiang, W; Li, J; Li, Z; Liu, D; Lu, Y; Shi, T; Wang, Z; Zhang, H; Zhang, J | 1 |
| Arra, C; Avallone, A; Bruzzese, F; Budillon, A; Chianese, MI; de Ruggiero, I; Di Cintio, A; Di Gennaro, E; Franco, R; Luciano, A; Moccia, T; Piro, G | 1 |
| Damante, G; Di Loreto, C; Pandolfi, M; Puglisi, F; Puppin, C | 1 |
| Flatmark, K; Fleten, KG; Furre, T; Hektoen, HH; Kristian, A; Ree, AH; Saelen, MG | 1 |
| Kang, YK; Kim, SY; Koo, DH; Lee, CW; Maeng, J; Na, YS; Park, I; Ryoo, BY; Ryu, MH; Yoo, C | 1 |
| Kang, YK; Lee, CW; Na, YS; Ryoo, BY; Ryu, MH; Yoo, C | 1 |
1 review(s) available for capecitabine and vorinostat
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for capecitabine and vorinostat
| Article | Year |
|---|---|
Phase I and pharmacodynamic study of vorinostat combined with capecitabine and cisplatin as first-line chemotherapy in advanced gastric cancer.
Topics: Acetylation; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Female; Fluorouracil; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Male; Middle Aged; Stomach Neoplasms; Vorinostat | 2014 |
Vorinostat in combination with capecitabine plus cisplatin as a first-line chemotherapy for patients with metastatic or unresectable gastric cancer: phase II study and biomarker analysis.
Topics: Acetylation; Adenocarcinoma; Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Capecitabine; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; Disease-Free Survival; Fatigue; Female; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Male; Middle Aged; Neoplasm Proteins; Neutropenia; Protein Processing, Post-Translational; Stomach Neoplasms; Thromboembolism; Treatment Outcome; Vorinostat | 2016 |
5 other study(ies) available for capecitabine and vorinostat
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Design, synthesis and biological evaluation of novel o-aminobenzamide derivatives as potential anti-gastric cancer agents in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cell Differentiation; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Female; Humans; Male; Mice; Mice, Inbred Strains; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Tumor Cells, Cultured | 2022 |
Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase.
Topics: Animals; Antineoplastic Agents; Apoptosis; Capecitabine; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Drug Synergism; Female; Floxuridine; Fluorouracil; Gene Expression Regulation, Enzymologic; Histone Deacetylase Inhibitors; Hydroxamic Acids; Mice; Mice, Inbred BALB C; Thymidine Phosphorylase; Thymidylate Synthase; Up-Regulation; Vorinostat; Xenograft Model Antitumor Assays | 2010 |
Histone deacetylase inhibitors induce thymidine phosphorylase expression in cultured breast cancer cell lines.
Topics: Breast Neoplasms; Capecitabine; Cell Line, Tumor; Cell Survival; Deoxycytidine; Drug Synergism; Female; Fluorouracil; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Immunohistochemistry; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thymidine Phosphorylase; Vorinostat | 2011 |
Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Female; Fluorouracil; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Hypoxia; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Radiation Tolerance; Radiation-Sensitizing Agents; Tumor Cells, Cultured; Vorinostat | 2012 |